European Leukemia Trial Registry
Trial: AML ATRA / Valproid acid

More Details
Short Title AML ATRA / Valproid acid
Trialgroup NN
Disease Myelodysplastic Syndrome(MDS) All subtypes
Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status Closed
Start of Recruitment 10.06.2003
Leader Ottmann, Prof. Dr., Oliver
Contactperson

Study Physician
Bug, PD Dr. med., Gesine
Tel: +49 (0)69 6301 7369
Fax: +49 (0)69 6301 7463
Email: g.bug@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 20.09.2006 Anja Hellenbrecht
changed 05.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org